HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lu Han Selected Research

TRPC3 cation channel

1/2020Protective mechanism of SIRT1 on Hcy-induced atrial fibrosis mediated by TRPC3.
10/2018Canonical transient receptor potential 3 channels in atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lu Han Research Topics

Disease

85Neoplasms (Cancer)
11/2022 - 11/2005
18Inflammation (Inflammations)
03/2022 - 10/2013
15Neoplasm Metastasis (Metastasis)
03/2022 - 10/2016
14Insulin Resistance
01/2021 - 01/2013
13Infections
10/2022 - 10/2008
13Breast Neoplasms (Breast Cancer)
01/2022 - 01/2013
12Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2013
10Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 03/2014
10Fibrosis (Cirrhosis)
01/2022 - 06/2014
9Atherosclerosis
01/2022 - 05/2015
8Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2013
8Type 2 Diabetes Mellitus (MODY)
08/2021 - 06/2014
8Nasopharyngeal Carcinoma
01/2020 - 02/2007
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2015
7Carcinoma (Carcinomatosis)
10/2021 - 01/2012
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 01/2013
6Myocardial Infarction
01/2022 - 11/2014
6Hypertension (High Blood Pressure)
01/2022 - 07/2014
5Prostatic Neoplasms (Prostate Cancer)
06/2022 - 03/2014
5Wounds and Injuries (Trauma)
01/2022 - 01/2017
5Aortic Dissection
01/2020 - 06/2017
4Heart Failure
06/2022 - 01/2019
4Virus Diseases (Viral Diseases)
01/2022 - 09/2015
4Melanoma (Melanoma, Malignant)
01/2022 - 11/2014
4Pain (Aches)
10/2021 - 10/2013
4Body Weight (Weight, Body)
03/2021 - 08/2010
4Lung Neoplasms (Lung Cancer)
01/2021 - 01/2013
4Heart Diseases (Heart Disease)
01/2021 - 09/2013
4Atrial Fibrillation
10/2020 - 11/2019
4Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 03/2015
4Vascular Remodeling
01/2020 - 12/2015
3Acute Kidney Injury (Acute Renal Failure)
02/2022 - 12/2018
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 02/2016
3Vitamin D Deficiency
01/2022 - 07/2014
3Hypoxia (Hypoxemia)
01/2022 - 10/2018
3Atrophy
12/2021 - 01/2020
3COVID-19
11/2021 - 12/2020
3Obesity
10/2021 - 07/2014
3Hyperlipidemias (Hyperlipidemia)
10/2021 - 01/2018
3Multiple Myeloma
10/2021 - 06/2011
3Hypertrophy
08/2021 - 09/2013
3Renal Cell Carcinoma (Grawitz Tumor)
03/2021 - 01/2021
3Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 01/2020
3Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2018
3Dyslipidemias (Dyslipidemia)
01/2021 - 01/2018
3Renal Insufficiency (Renal Failure)
01/2021 - 12/2018
3Carcinogenesis
01/2021 - 04/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2021 - 10/2014
3Hyperekplexia
01/2021 - 04/2012
3Diabetes Mellitus
11/2020 - 01/2014
3Stiff-Person Syndrome (Stiff Man Syndrome)
10/2020 - 01/2011
3Leiomyoma (Uterine Fibroids)
09/2020 - 11/2017

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
03/2022 - 09/2007
21Pharmaceutical PreparationsIBA
01/2022 - 04/2012
17Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
13CytokinesIBA
04/2022 - 01/2013
13MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
12Biological ProductsIBA
12/2021 - 09/2007
7Messenger RNA (mRNA)IBA
03/2022 - 12/2016
7Peptides (Polypeptides)IBA
01/2022 - 05/2014
7Long Noncoding RNAIBA
01/2022 - 03/2015
7Glucose (Dextrose)FDA LinkGeneric
08/2021 - 06/2014
6CollagenIBA
01/2022 - 06/2014
6CholesterolIBA
01/2021 - 06/2014
5RNA (Ribonucleic Acid)IBA
03/2022 - 01/2012
5Small Interfering RNA (siRNA)IBA
01/2022 - 05/2014
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2010
5LigandsIBA
01/2021 - 05/2014
5Apolipoproteins E (ApoE)IBA
01/2019 - 12/2017
4Therapeutic UsesIBA
01/2022 - 08/2017
4Triglycerides (Triacylglycerol)IBA
01/2022 - 06/2014
4Circular RNAIBA
01/2022 - 10/2020
4Antiviral Agents (Antivirals)IBA
01/2022 - 09/2015
4Angiotensin IIIBA
10/2021 - 09/2013
4EnzymesIBA
08/2021 - 06/2017
4LipidsIBA
08/2021 - 07/2014
4Glycine Receptors (Glycine Receptor)IBA
10/2020 - 01/2011
4Indicators and Reagents (Reagents)IBA
02/2019 - 10/2017
4ProstaglandinsIBA
10/2016 - 10/2013
3Immune Checkpoint InhibitorsIBA
06/2022 - 02/2021
3AntibodiesIBA
01/2022 - 01/2019
3hydroxide ionIBA
01/2022 - 07/2014
3Vitamin DFDA LinkGeneric
01/2022 - 07/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2013
3HydrogelsIBA
01/2022 - 01/2017
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 06/2011
3retronectinIBA
08/2021 - 01/2016
3Chimeric Antigen ReceptorsIBA
08/2021 - 01/2020
3Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2021 - 10/2013
3Phosphotransferases (Kinase)IBA
01/2021 - 01/2019
3AntioxidantsIBA
12/2020 - 09/2006
3Analgesics (Analgesic Drugs)IBA
02/2020 - 10/2013

Therapy/Procedure

38Therapeutics
11/2022 - 02/2010
17Drug Therapy (Chemotherapy)
06/2022 - 02/2010
10Radiotherapy
06/2022 - 11/2005
9Immunotherapy
01/2022 - 01/2018
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 01/2015
3Aftercare (After-Treatment)
01/2021 - 11/2009
3Precision Medicine
01/2021 - 03/2017
3Percutaneous Coronary Intervention
12/2020 - 01/2014